About
Mehrdad Shamloo is a Stanford neuroscientist focused on neurodegenerative disease, cognition, neuroinflammation, and translational CNS drug discovery. He is Professor (Research) of Neurosurgery at Stanford, directs the Behavioral and Functional Neuroscience Laboratory, and has helped launch Stanford-originated biotech companies including CuraSen Therapeutics, Evia Therapeutics, and Longieva Therapeutics. Public sources position him primarily as a scientific founder and academic advisor whose research has been translated into neurotherapeutic programs.
Areas of interest
neuroscienceneurodegenerative diseaseAlzheimer's diseaseParkinson's diseasecognitionneuroinflammationCNS drug discoverytranslational medicinebrain disorderstherapeutics